US Equity
EXEL
— EXELIXIS, INC.Exelixis is an oncology-focused biotechnology company that develops and commercializes cancer therapies, including treatments for kidney, liver, and thyroid cancers.
💰 Market cap: $14.03B📍 1851 Harbor Bay Parkway, ALAMEDA, CA, 94502 US🏷️ Biotechnology & Medical Research💵 Previous close: $55.37🔢 9,878 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $55.37 |
| 2026-07-23 | $55.65 |
| 2026-07-22 | $54.98 |
| 2026-07-21 | $56.12 |
| 2026-07-20 | $55.53 |
| 2026-07-17 | $55.92 |
| 2026-07-16 | $55.68 |
| 2026-07-15 | $55.55 |
| 2026-07-14 | $55.77 |
| 2026-07-13 | $56.04 |
| 2026-07-10 | $56.50 |
| 2026-07-09 | $57.10 |
| 2026-07-08 | $56.11 |
| 2026-07-07 | $57.08 |
| 2026-07-06 | $55.53 |
| 2026-07-02 | $55.85 |
| 2026-07-01 | $53.96 |
| 2026-06-30 | $54.41 |
| 2026-06-29 | $54.28 |
| 2026-06-26 | $54.77 |
| 2026-06-25 | $53.23 |
| 2026-06-24 | $52.87 |
| 2026-06-23 | $51.34 |
| 2026-06-22 | $51.35 |
| 2026-06-18 | $51.91 |
| 2026-06-17 | $52.44 |
| 2026-06-16 | $52.10 |
| 2026-06-15 | $53.00 |
| 2026-06-12 | $53.13 |
| 2026-06-11 | $53.50 |
| 2026-06-10 | $52.58 |
| 2026-06-09 | $52.99 |
| 2026-06-08 | $51.74 |
| 2026-06-05 | $52.70 |
| 2026-06-04 | $52.49 |
| 2026-06-03 | $51.60 |
| 2026-06-02 | $48.54 |
| 2026-06-01 | $50.28 |
| 2026-05-29 | $50.48 |
| 2026-05-28 | $51.45 |
| 2026-05-27 | $50.03 |
| 2026-05-26 | $49.98 |
| 2026-05-22 | $50.15 |
| 2026-05-21 | $49.65 |
| 2026-05-20 | $49.90 |
| 2026-05-19 | $48.67 |
| 2026-05-18 | $49.84 |
| 2026-05-15 | $50.13 |
| 2026-05-14 | $51.10 |
| 2026-05-13 | $51.29 |
| 2026-05-12 | $49.46 |
| 2026-05-11 | $49.71 |
| 2026-05-08 | $48.16 |
| 2026-05-07 | $46.21 |
| 2026-05-06 | $48.70 |
| 2026-05-05 | $44.42 |
| 2026-05-04 | $44.17 |
| 2026-05-01 | $43.68 |
| 2026-04-30 | $44.46 |
| 2026-04-29 | $44.69 |
| 2026-04-28 | $44.93 |